Status:
ACTIVE_NOT_RECRUITING
Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to collect blood samples, as well as tumor tissue for genetic analysis. The collection of samples will allow the creation of a plasma bank. Targeted individuals are cancer...
Eligibility Criteria
Inclusion
- Patients with cancer treated with one of the following regimens: Molecular targeted agents or Immunotherapy
- Paraffin-embedded tumor tissue available for immunohistochemistry and/or DNA extraction.
- Patient able to give written informed consent.
Exclusion
- Patients with cancer treated with other regimen
Key Trial Info
Start Date :
July 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03835520
Start Date
July 11 2018
End Date
May 1 2028
Last Update
December 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cliniques Universitaires Saint-Luc
Brussels, Belgium, 1200